Skip to main content
. 2013 Mar 19;8(3):e58995. doi: 10.1371/journal.pone.0058995

Figure 5. In-vivo TMZ concentration measurement.

Figure 5

(a) Measured TMZ concentrations (in µg/ µL) in cerebrospinal fluid (CSF) and blood plasma in animals treated with TMZ only (TMZ; n = 4) or combined TMZ with FUS-BBB opening (TMZ+FUS; n = 6). (b) Corresponding CSF/Plasma ratios (in %) determined from (a) (p = 0.06).